Alan Sebulsky bought $250k of PBLS
director at Parabilis Medicines, Inc.. 12,500 shares at an average of $20.00, traded Jun 11, 2026, filed Jun 15, 2026.
Score components
- +15RoleDirector
- +13Trade size$250k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- +15Cluster3 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-271324, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | POpen-market purchase Common Stockindirect: By Apothecary Capital LLC | +12,500 | $20.00 | $250k | 12,500 | Jun 15, 2026 |
Related signals
Other insiders at Parabilis Medicines, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 35Weak | PBLSbuy Parabilis Medicines, Inc. | Ra Capital Management, L.p. director, owner | $6.9M 244,593 shares | +1% | |
| 57Moderate | Parabilis Medicines, Inc. | Guy Levy owner | $10M 500,000 shares | +77% | |
| 62Notable | Parabilis Medicines, Inc. | Alan Sebulsky director | $474k 17,500 shares | +140% | |
| 60Notable | Parabilis Medicines, Inc. | Ra Capital Management, L.p. director, owner | $424M 21,188,750 shares | +323% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.